Open AccessClinical role of apolipoproteins A and B
Author(s) -
Г. А. Чумакова,
О. В. Гриценко,
Н. Г. Веселовская,
Е. В. Вахромеева,
А. А. Козаренко
Publication year - 2011
Publication title -
kardiovaskulârnaâ terapiâ i profilaktika
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.158
H-Index - 16
eISSN - 2619-0125
pISSN - 1728-8800
DOI - 10.15829/1728-8800-2011-6-105-111
Subject(s) - apolipoprotein b , dyslipidemia , medicine , cardiology , coronary atherosclerosis , coronary artery disease , cholesterol , obesity
The assessment and correction of the traditional parameters of atherogenic dyslipidemia are important, but not exclusive methods in the management of atherosclerosis, including coronary artery atherosclerosis. More accurate diagnostic and therapeutic assessment requires the measurement of apolipoprotein (Apo) A, ApoB, and their ratio.Lower ApoB/ApoAI ratio values denote lower levels of cardiovascular risk.